GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Shin Nippon Biomedical Laboratories Ltd (FRA:YB3) » Definitions » Price-to-Free-Cash-Flow

Shin Nippon Biomedical Laboratories (FRA:YB3) Price-to-Free-Cash-Flow : N/A (As of Apr. 17, 2025)


View and export this data going back to 2004. Start your Free Trial

What is Shin Nippon Biomedical Laboratories Price-to-Free-Cash-Flow?

As of today (2025-04-17), Shin Nippon Biomedical Laboratories's share price is €7.55. Shin Nippon Biomedical Laboratories's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 was €0.00. Hence, Shin Nippon Biomedical Laboratories's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Shin Nippon Biomedical Laboratories's Price-to-Free-Cash-Flow or its related term are showing as below:

FRA:YB3's Price-to-Free-Cash-Flow is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 22.755
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Shin Nippon Biomedical Laboratories's Free Cash Flow per Share for the three months ended in Sep. 2024 was €0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was €0.00.

During the past 13 years, Shin Nippon Biomedical Laboratories's highest 3-Year average Free Cash Flow per Share Growth Rate was 123.30% per year. The lowest was -83.40% per year. And the median was 13.15% per year.


Shin Nippon Biomedical Laboratories Price-to-Free-Cash-Flow Historical Data

The historical data trend for Shin Nippon Biomedical Laboratories's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shin Nippon Biomedical Laboratories Price-to-Free-Cash-Flow Chart

Shin Nippon Biomedical Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.29 8.02 16.27 - -

Shin Nippon Biomedical Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Shin Nippon Biomedical Laboratories's Price-to-Free-Cash-Flow

For the Diagnostics & Research subindustry, Shin Nippon Biomedical Laboratories's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shin Nippon Biomedical Laboratories's Price-to-Free-Cash-Flow Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Shin Nippon Biomedical Laboratories's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Shin Nippon Biomedical Laboratories's Price-to-Free-Cash-Flow falls into.


;
;

Shin Nippon Biomedical Laboratories Price-to-Free-Cash-Flow Calculation

Shin Nippon Biomedical Laboratories's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=7.55/0
=N/A

Shin Nippon Biomedical Laboratories's Share Price of today is €7.55.
Shin Nippon Biomedical Laboratories's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Shin Nippon Biomedical Laboratories  (FRA:YB3) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Shin Nippon Biomedical Laboratories Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Shin Nippon Biomedical Laboratories's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Shin Nippon Biomedical Laboratories Business Description

Traded in Other Exchanges
Address
8-1 Akashi-cho, Tokyo, JPN
Shin Nippon Biomedical Laboratories Ltd provides pre-clinical testing services in the pharmaceutical industry in Japan. The company provides a range of services such as pre-clinical and analysis studies, contracted clinical trials, SMO, CRO, translational research and cancer treatment.

Shin Nippon Biomedical Laboratories Headlines

No Headlines